Detalhe da pesquisa
1.
Outcomes of a universal germline screening program in a community urology practice.
Clin Genet
; 2024 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38711401
2.
Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
Prostate
; 81(7): 427-432, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33760238
3.
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
Prostate
; 81(7): 433-439, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33792945
4.
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA.
J Immunother Cancer
; 8(2)2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32788235
5.
Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort.
Front Oncol
; 10: 581189, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33194712